Partner of man who sought MAID after ER bedsore says hospital staff wouldn't listen to her
Sylvie Brosseau gave an emotional testimony at the public coroner's inquiry into Normand Meunier's death. Meunier died in 2024 after he developed a severe bedsore during a stay at a Saint-Jérôme, Que., hospital.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Cohere launches AI health care agents in the U.S.
Canadian artificial intelligence company Cohere Inc. is entering the health care industry through a partnership with U.S.-based Ensemble Health Partners that uses AI agents to help hospitals and other providers manage their revenue. Cohere, founded in 2019, uses large-language models to build chatbots and generative-AI platforms for enterprise customers to automate some tasks. The partnership with Ensemble, launched Tuesday, uses a customized version of the North by Cohere platform that will run on health care providers' internal systems and help with tasks such as hospitals appealing insurance-claim denials and chasing down accounts receivable. The company said pre-launch tests of the tools accelerated denial appeals by 40 per cent and improved denial overturn rates by 15 per cent. Running on internal systems is a key part of how the AI system protects the safety of patients' information and complies with privacy law, said Cohere co-founder Ivan Zhang. 'There's no data leaving their system, because all the agents are in the house,' he said. Because of those privacy concerns, Mr. Zhang said the AI has to be trained on synthetic data, which would be similar to real-world data in likeness and structure but without any protected personal information. The foray into health-care follows Cohere's work in the financial sector, which has to adhere to similar privacy rules. In January, the company announced a partnership with Royal Bank of Canada to co-develop and run a customized platform called North for Banking which, among other things, helps employees answer questions from customers. Mr. Zhang said Cohere is focused on the U.S. market for now, but hopes to have more to announce for Canadian health-care soon. 'So far, we are focused on the U.S. markets. We want to take these learnings and adapt it to different systems in Canada and globally,' he said. Cohere did not disclose any financial terms or which U.S. clients are using the AI platform. The company also received a nod Tuesday from new federal AI minister Evan Solomon. In a speech in Ottawa, Mr. Solomon outlined the government's new approach to AI, saying it would shift from 'warnings and regulation' to celebrating industry 'champions' such as Cohere. Mr. Zhang said he was 'delighted' by the support and said there was a strong case to be made that investments in AI were part of strengthening Canada's economy and security. 'We've been very happy about the government's engagement so far,' he said.
National Post
an hour ago
- National Post
Next-Level Skin Rejuvenation: Canada MedLaser Launches Exosome Therapy with Microneedling in Ontario
Article content Article content TORONTO — Canada MedLaser Clinics, a leading and trusted name in medical aesthetics across Ontario, proudly announces the launch of its newest offering: Exosome Therapy combined with Microneedling. This advanced, non-invasive regenerative skincare solution is now available at all clinic locations, ushering in a new era of natural skin rejuvenation and repair. Article content Article content This advanced skincare treatment brings together two powerful technologies— Microneedling, known for stimulating collagen production, and Exosome Therapy, which delivers regenerative stem cell-derived nano-vesicles to revitalize the skin from within. Together, they help restore skin's youthful glow, improve texture and tone, and support deep cellular healing—often with visible results in just a few sessions. Article content With this launch, Canada MedLaser Clinics continues its mission to blend cutting-edge medical science with thoughtful aesthetic care. The team believes this new offering is a meaningful step forward for clients seeking real results with minimal disruption to their busy lives. Article content Exosomes Article content are microscopic, messenger-rich vesicles (30–150 nanometers) that carry growth factors, proteins, and RNA (ribonucleic acid)—naturally supporting the body's repair mechanisms. When applied topically following microneedling, these exosomes penetrate more deeply and efficiently, supercharging the skin's ability to restore itself. The treatment is especially effective for fine lines, acne scars, sun damage, and dull or uneven skin. Article content Unlike more invasive options, this gentle-yet-powerful treatment is safe for a wide variety of skin types—including sensitive skin—and involves little to no downtime, allowing patients to quickly resume their daily activities. Treatments are carefully personalized based on each client's specific skin condition and aesthetic goals, and are expertly delivered by our certified medical aestheticians in a controlled, clinical setting, ensuring utmost safety and efficacy. Article content Now available at Canada MedLaser's clinics in Toronto, Mississauga, Vaughan, and Yorkville, this new therapy underscores the company's continued dedication to offering the most effective and innovative treatments in the aesthetics field. Article content About Canada MedLaser Clinics Article content Canada MedLaser Clinics is a top-tier provider of advanced skin and laser treatments, recognized for seamlessly integrating innovative technology with personalized client care. With a growing network of modern clinics across Ontario and a dedicated team of certified professionals, the company offers a comprehensive range of services, including advanced anti-aging skincare solutions, cosmetic injections, and laser treatments for men and women. Canada MedLaser is committed to delivering exceptional safety, proven efficacy, and consistently natural-looking results that enhance each client's unique beauty. Article content Article content Article content
CTV News
an hour ago
- CTV News
‘It's time for us to go to work': John Davidson makes a last walk, but says the journey will continue
John Davidson takes a 30km walk to mark 30 years since the original Jesse's Journey walk, on June 10, 2025. (Gerry Dewan/CTV News London) A last walk, but the journey continues. On Tuesday, John Davidson marked the 30th anniversary of his Jesse's Journey Walk across Ontario with a 30 kilometer walk from St. Thomas to London. Supporters gathered at the Jumbo the elephant monument in St. Thomas to commemorate the anniversary. It was May 20, 1995, that John Davidson and his 15-year-old son Jesse started their inspirational 124-day trek from the Manitoba border, across Ontario, to Ottawa. Peter Garland, past board president of Jesse's Journey charity, recounted the effort during a short ceremony, 'There's a father and his son moving people to tears, going down the highway, never stopping.' Jesse was six when he was diagnosed with Duchenne muscular dystrophy, a fatal genetic disorder affecting one in 5,000 boys. Jesse's parents and friends committed to raising funds to help find treatments and, eventually, a cure. John Davidson John Davidson and supporters walked from St. Thomas to London on June 10, 2025. (Gerry Dewan/CTV News London) On this day John Davidson was walking from St. Thomas to Victoria Park in London. Davidson, just shy of his 80th birthday, told the gathering in St. Thomas that this will be the last walk he will make on behalf of the cause, which has meant so much to himself and so many others. But he stressed that his advocacy would continue. He told CTV News the focus now is getting approvals for medications that are available in other countries, but not in Canada, 'The drugs are not going to reverse Duchenne muscular dystrophy, but they will slow it down tremendously to change your quality of life.' The drugs are available in the United States, the United Kingdom, and the European Union. Anna Vockeroth's son Spencer was diagnosed with Duchenne muscular dystrophy last year, shortly after he turned five. She's anxious to get access to the emerging treatment, 'I'm hearing about it. I read about it, and I'm in all of the groups. We don't have a lot here yet.' John Davidson Anna Vockeroth, son Spencer, and husband Tom, get their picture taken with John Davidson on June 10, 2025. (Gerry Dewan/CTV News London) Vockeroth said prior to Spencer's diagnosis, that his stumbles and falls were signs of something more serious. She trusted her instincts and pressed for extensive testing. Now she's trusting her instincts again, 'Just as I felt it in my gut, that there is something wrong with him, I feel like there's something better coming, and soon.' St. Thomas Mayor Joe Preston, a former MP, said he will join Davidson's lobbying effort, 'Canada needs to be in first place; never not. John recognized that. In his heart, and with Jesse in his mind, he makes sure that happens.' According to Davidson, 'It's time for us to go to work on this and find a way to get those here to make a difference in the lives of all those boys, some of whom are here this morning. They're just like Jesse at that age and that's why I'm on the road one last time.' Jesse's Journey now operates as Defeat Duchenne Canada and has contributed more than $19 million to research.
